Evidence map›Paper›PMID 35205838›Full record

ArticleCancers2022

Mental Health and Quality of Life among Patients with Cancer during the SARS-CoV-2 Pandemic: Results from the Longitudinal ONCOVID Survey Study.

Emiel A De Jaeghere, Heini Kanervo, Roos Colman, Wim Schrauwen, Paulien West, Nele Vandemaele, Aglaja De Pauw, Celine Jacobs, Ingeborg Hilderson, Michael Saerens and 8 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.5field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 25 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Predicting psychological distress in advanced ovarian cancer patients during the COVID-19 pandemic.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 3 institutions in 1 country.

Emiel A De JaeghereMedical Oncology Department, Ghent University Hospital, 9000 Ghent, Belgium.ORCID 0000-0001-6314-6179
Heini KanervoMedical Oncology Department, Ghent University Hospital, 9000 Ghent, Belgium.
Roos ColmanBiostatistics Unit, Faculty of Medicine and Life Sciences, Ghent University, 9000 Ghent, Belgium.
Wim SchrauwenMedical Psychology Department, Ghent University Hospital, 9000 Ghent, Belgium.
Paulien WestFaculty of Medicine and Life Sciences, Ghent University, 9000 Ghent, Belgium.ORCID 0000-0001-7287-9657
Nele VandemaeleFaculty of Medicine and Life Sciences, Ghent University, 9000 Ghent, Belgium.
Aglaja De PauwMedical Oncology Department, Ghent University Hospital, 9000 Ghent, Belgium.
Celine JacobsMedical Oncology Department, Ghent University Hospital, 9000 Ghent, Belgium.ORCID 0000-0001-5286-3519
Ingeborg HildersonMedical Oncology Department, Ghent University Hospital, 9000 Ghent, Belgium.
Michael SaerensMedical Oncology Department, Ghent University Hospital, 9000 Ghent, Belgium.
Nora SundahlCancer Research Institute Ghent (CRIG), 9000 Ghent, Belgium.
Katrien VandecasteeleCancer Research Institute Ghent (CRIG), 9000 Ghent, Belgium.
Eline NaertMedical Oncology Department, Ghent University Hospital, 9000 Ghent, Belgium.
Lore LapeireMedical Oncology Department, Ghent University Hospital, 9000 Ghent, Belgium.
Vibeke KruseCancer Research Institute Ghent (CRIG), 9000 Ghent, Belgium.
Sylvie RotteyMedical Oncology Department, Ghent University Hospital, 9000 Ghent, Belgium.
Gilbert LemmensPsychiatry Department, Ghent University Hospital, 9000 Ghent, Belgium.
Hannelore G DenysMedical Oncology Department, Ghent University Hospital, 9000 Ghent, Belgium.ORCID 0000-0002-8897-9430
Ghent University Hospital · BEGhent University · BECancer Research Institute Ghent · BE

Funding

Kom Op Tegen Kanker N/A
6 · The paper itself

Abstract

purposeThis longitudinal survey study aimed to investigate the self-reported outcome measures of COVID-19 peritraumatic distress, depression, anxiety, stress, quality of life (QOL), and their associated factors in a cohort of cancer patients treated at a tertiary care hospital during the SARS-CoV-2 pandemic.

methodsSurveys were administered at four time points between 1 April 2020 and 18 September 2020. The surveys included the CPDI, DASS-21, and WHOQOL-BREF questionnaires.

resultsSurvey response rates were high (61.0% to 79.1%). Among the 355 participants, 71.3% were female, and the median age was 62.2 years (IQR, 53.9 to 69.1). The majority (78.6%) were treated with palliative intention. An important proportion of the participants reported symptoms of COVID-19 peritraumatic distress (34.2% to 39.6%), depression (27.6% to 33.5%), anxiety (24.9% to 32.7%), and stress (11.4% to 15.7%) at any time point during the study period. We did not find clinically meaningful mental health and QOL differences during the study period, with remarkably little change in between the pandemic's first and second wave. We found no consistent correlates of mental health or QOL scores, including cancer type, therapy intention, and sociodemographic information.

conclusionThis cohort of cancer patients showed considerable resilience against mental health and QOL deterioration during the SARS-CoV-2 pandemic.

Indexed as

cancercoronavirus 2019mental healthpandemicquality of lifeSARS-CoV-2

Identifiers

PMID35205838
PMCPMC8869927
OpenAlexW4213170013

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.